Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database

Lu, Hsueh-JuHsueh-JuLuHsieh, Meng-CheMeng-CheHsiehWang, Hung-MingHung-MingWangHsieh, Jason Chia-HsunJason Chia-HsunHsiehYen, Chia-JuiChia-JuiYenWu, Shang-YinShang-YinWuHUAI-CHENG HUANGWang, Hui-ChingHui-ChingWangChu, Pen-YuanPen-YuanChuChen, Tien-HuaTien-HuaChenChien, Chih-YenChih-YenChienHuang, Tai-LinTai-LinHuangChang, Yi-FangYi-FangChangHua, Chun-HungChun-HungHuaLien, Ming-YuMing-YuLienJO-PAI CHENLu, Wei-ChenWei-ChenLuLin, Jin-ChingJin-ChingLinWang, Chen-ChiChen-ChiWangLiu, Yi-ChunYi-ChunLiuYang, Muh-HwaMuh-HwaYangPEI-JEN LOU2024-03-242024-03-242024-0510433074https://scholars.lib.ntu.edu.tw/handle/123456789/641275For R/M HNSCC, the differences in prognosis and treatment options between distant metastasis (DM) and locoregional recurrence, especially in the DM group, remain unclear.enbiomarkers; cetuximab; distant metastasis; head and neck squamous cell carcinoma; lactate dehydrogenase[SDGs]SDG3Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry databasejournal article10.1002/hed.27681383859702-s2.0-85186400560https://api.elsevier.com/content/abstract/scopus_id/85186400560